- Report
- August 2025
- 190 Pages
Global
From €3136EUR$3,545USD£2,703GBP
€3484EUR$3,939USD£3,004GBP
- Report
- August 2025
- 365 Pages
Global
From €5174EUR$5,850USD£4,461GBP
- Book
- December 2024
- 1440 Pages
- Book
- November 2021
North America
- Book
- October 2021
North America
Autoinflammatory Disease is a type of disorder that is related to Allergy and Immunology. It is characterized by recurrent episodes of inflammation without any known cause. Symptoms can include fever, rash, joint pain, and fatigue. Treatment typically involves the use of non-steroidal anti-inflammatory drugs, corticosteroids, and biologic agents.
Autoinflammatory Disease is a growing area of research and treatment. It is estimated that up to 1% of the population may be affected by an autoinflammatory disorder. Diagnosis is often difficult due to the lack of specific tests and the wide range of symptoms.
Some companies in the Autoinflammatory Disease market include AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more